about
Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.Ensemble Architecture for Prediction of Enzyme-ligand Binding Residues Using Evolutionary Information.A Computational Approach for Prioritizing Selection of Therapies Targeting Drug Resistant Variation in Anaplastic Lymphoma Kinase.Ranking Enzyme Structures in the PDB by Bound Ligand Similarity to Biological Substrates.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Modeling enzyme-ligand binding in drug discovery
@ast
Modeling enzyme-ligand binding in drug discovery
@en
Modeling enzyme-ligand binding in drug discovery
@nl
type
label
Modeling enzyme-ligand binding in drug discovery
@ast
Modeling enzyme-ligand binding in drug discovery
@en
Modeling enzyme-ligand binding in drug discovery
@nl
prefLabel
Modeling enzyme-ligand binding in drug discovery
@ast
Modeling enzyme-ligand binding in drug discovery
@en
Modeling enzyme-ligand binding in drug discovery
@nl
P2093
P2860
P1476
Modeling enzyme-ligand binding in drug discovery
@en
P2093
Dušanka Janežič
Janez Konc
Samo Lešnik
P2860
P2888
P356
10.1186/S13321-015-0096-0
P577
2015-12-01T00:00:00Z
P5875
P6179
1047840160